Neuland Laboratories Board Meeting on Nov 3 for Q2 FY27 Results

Neuland Laboratories Ltd has announced a Board of Directors meeting scheduled for November 3, 2026. The primary agenda is to consider and approve the unaudited financial results for the quarter and half-year ended September 30, 2026. These results will be both standalone and consolidated. Concurrently, the company has extended its trading window closure, which began on October 1, 2026, and will remain shut until 48 hours after the financial results are declared. This measure is in accordance with the company's Insider Trading Code.